1-13 of 13
Amy E. DeZern
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modified Delphi panel consensus recommendations for management of severe aplastic anemia

Daria V. Babushok, Amy E. DeZern, Carlos M. de Castro, Zora R. Rogers, David Beenhouwer, Michael S. Broder, Suzanne R. Fanning, Sarah N. Gibbs, Rabi Hanna, Jaroslaw P. Maciejewski, Bart L. Scott, Srinivas K. Tantravahi, Marcin W. Wlodarski, Irina Yermilov, Bhumika J. Patel
Journal: Blood Advances
Blood Adv (2024) 8 (15): 3946–3960.
https://doi.org/10.1182/bloodadvances.2023011642
Published: 2024
Includes: Supplemental data
Journal Articles

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts

In Young Choi, Jonathan P. Ling, Jian Zhang, Eric Helmenstine, Wencke Walter, Panagiotis Tsakiroglou, Riley E. Bergman, Céline Philippe, James L. Manley, Kevin Rouault-Pierre, Bing Li, Daniel H. Wiseman, Kiran Batta, Madhu Ouseph, Elsa Bernard, Benjamin Dubner, Xiao Li, Torsten Haferlach, Anna Koget, Salman Fazal, Tania Jain, Christopher D. Gocke, Amy E. DeZern, William Brian Dalton
Journal: Blood Advances
Blood Adv (2024) 8 (15): 3961–3971.
https://doi.org/10.1182/bloodadvances.2023011260
Published: 2024
Includes: Supplemental data
Journal Articles

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Clinical Trials & Observations
Edward J. Gorak, Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu, Rafael Bejar, Steven D. Gore, Steven H. Kroft, Alexandra Harrington, Wael Saber, Daniel Starczynowski, Dana E. Rollison, Ling Zhang, Lynn Moscinski, Steffanie Wilson, Jason Thompson, Christine Borchert, Seth Sherman, Donnie Hebert, Mary Ellen Walker, Eric Padron, Amy E. DeZern, Mikkael A. Sekeres
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6120–6129.
https://doi.org/10.1182/bloodadvances.2023010061
Published: 2023
Includes: Supplemental data
Journal Articles

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes

Sergiu Pasca, Matthew Z. Guo, Shiyu Wang, Kristin Stokvis, Audra Shedeck, Aparna Pallavajjala, Cynthia Shams, Roshni Pallavajjala, Amy E. DeZern, Ravi Varadhan, Christopher D. Gocke, Richard J. Jones, Lukasz P. Gondek
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4660–4670.
https://doi.org/10.1182/bloodadvances.2023010416
Published: 2023
Includes: Supplemental data
Journal Articles

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Amy E. DeZern, Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H. Wilson, Donnie Hebert, Joachim Deeg, Ling Zhang, Steven Gore, Tareq Al Baghdadi, Jaroslaw Maciejewski, Jane Liu, Eric Padron, Rami Komrojki, Wael Saber, Gregory Abel, Steven H. Kroft, Alexandra Harrington, Tyler Grimes, Harrison Reed, Robert S. Fulton, Nancy L. DiFronzo, Nancy Gillis, Mikkael A. Sekeres, Matthew J. Walter
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3749–3759.
https://doi.org/10.1182/bloodadvances.2022008578
Published: 2023
Includes: Supplemental data
Journal Articles

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Clinical Trials & Observations
Maximilian Stahl, Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F. Sanz, David A. Sallman, Valeria Santini, Gail J. Roboz, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Aziz Nazha, Stephen D. Nimer, Ravindra Majeti, Richard F. Little, Steven Gore, Alan F. List, Vijay Kutchroo, Rami S. Komrokji, Tae Kon Kim, Nina Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Peter L. Greenberg, Maria Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Matteo G. Della Porta, Naval G. Daver, Jane E. Churpek, Hetty E. Carraway, Andrew M. Brunner, Uma Borate, John M. Bennett, Rafael Bejar, Jacqueline Boultwood, Sanam Loghavi, Jan Philipp Bewersdorf, Uwe Platzbecker, David P. Steensma, Mikkael A. Sekeres, Rena J. Buckstein, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2709–2714.
https://doi.org/10.1182/bloodadvances.2022008747
Published: 2023
Journal Articles

Approach to the diagnosis of aplastic anemia

Amy E. DeZern, Jane E. Churpek
Journal: Blood Advances
Blood Adv (2021) 5 (12): 2660–2671.
https://doi.org/10.1182/bloodadvances.2021004345
Published: 2021
Journal Articles

Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide

Clinical Trials & Observations
Amy E. DeZern, Clio Franklin, Hua-Ling Tsai, Phil Hollingsworth Imus, Kenneth R. Cooke, Ravi Varadhan, Richard J. Jones
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1360–1368.
https://doi.org/10.1182/bloodadvances.2020003922
Published: 2021
Includes: Supplemental data
Journal Articles

Allogeneic transplantation for Ph + acute lymphoblastic leukemia with posttransplantation cyclophosphamide

Clinical Trials & Observations
Jonathan A. Webster, Leo Luznik, Hua-Ling Tsai, Philip H. Imus, Amy E. DeZern, Keith W. Pratz, Mark J. Levis, Ivana Gojo, Margaret M. Showel, Gabrielle Prince, Javier Bolaños-Meade, Lukasz P. Gondek, Gabriel Ghiaur, W. Brian Dalton, Tania Jain, Ephraim J. Fuchs, Douglas E. Gladstone, Christian B. Gocke, Syed Abbas Ali, Carol Ann Huff, Ivan M. Borrello, Lode Swinnen, Nina Wagner-Johnston, Richard F. Ambinder, Richard J. Jones, B. Douglas Smith
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5078–5088.
https://doi.org/10.1182/bloodadvances.2020002945
Published: 2020
Includes: Supplemental data
Journal Articles

Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide

Clinical Trials & Observations
Amy E. DeZern, Marianna L. Zahurak, Heather J. Symons, Kenneth R. Cooke, Gary L. Rosner, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Philip Imus, Ivan Borrello, Nina Wagner-Johnston, Richard F. Ambinder, Leo Luznik, Javier Bolaños-Meade, Ephraim J. Fuchs, Richard J. Jones, Robert A. Brodsky
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020001729
Published: 2020
Includes: Supplemental data
Journal Articles

The K666N mutation in SF3B1 is associated with increased progression of MDS and distinct RNA splicing

W. Brian Dalton, Eric Helmenstine, Lisa Pieterse, Bing Li, Christopher D. Gocke, Joshua Donaldson, Zhijian Xiao, Lukasz P. Gondek, Gabriel Ghiaur, Ivana Gojo, B. Douglas Smith, Mark J. Levis, Amy E. DeZern
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1192–1196.
https://doi.org/10.1182/bloodadvances.2019001127
Published: 2020
Includes: Supplemental data
Journal Articles

Stem cell donors should be screened for CHIP

Amy E. DeZern, Lukasz P. Gondek
Journal: Blood Advances
Blood Adv (2020) 4 (4): 784–788.
https://doi.org/10.1182/bloodadvances.2019000394
Published: 2020
Journal Articles

Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia

Clinical Trials & Observations
Brian Ball, Rami S. Komrokji, Lionel Adès, Mikkael A. Sekeres, Amy E. DeZern, Lisa Pleyer, Norbert Vey, Antonio Almeida, Ulrich Germing, Thomas Cluzeau, Uwe Platzbecker, Steven D. Gore, Pierre Fenaux, Thomas Prebet
Journal: Blood Advances
Blood Adv (2018) 2 (16): 2063–2071.
https://doi.org/10.1182/bloodadvances.2018015529
Published: 2018
Includes: Supplemental data